Literature DB >> 2496029

Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and from non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M. avium.

A J Crowle1, D L Cohn, P Poche.   

Abstract

Some characteristics of the sera and macrophages (MP) of human immunodeficiency virus (HIV)-infected patients which might contribute to their unusual susceptibility to Mycobacterium avium infection were studied. Cultures of patient peripheral blood MP in medium supplemented with their sera or normal subject sera were infected with M. avium and compared with similar cultures of normal MP. Intracellular mycobacterial replication was measured in the infected MP by CFU counts of the bacteria made from lysed samples of the MP at 0, 4, and 7 days after MP infection. Sera from patients with chronic granulomatous infection with M. avium, but no HIV infection, also were studied. The sera from all of the patients with chronic granulomatous infection and from several HIV-infected patients were deficient or lacking in an inhibitor that in normal serum acts within normal MP to suppress intracellular growth of M. avium. Most of the HIV-infected patients also had MP that were abnormally permissive for M. avium because they responded poorly to the serum inhibitor. Elucidation of these associated defects in native defenses against M. avium may result in better prevention and therapy of M. avium infections.

Entities:  

Mesh:

Year:  1989        PMID: 2496029      PMCID: PMC313297          DOI: 10.1128/iai.57.5.1445-1451.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

Review 1.  Mycobacterium avium-intracellulare complex infections in the acquired immunodeficiency syndrome.

Authors:  J R Perfect
Journal:  J Electron Microsc Tech       Date:  1988-01

2.  Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages.

Authors:  A J Crowle; E J Ross; M H May
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Host defense against Mycobacterium-avium complex.

Authors:  S Schnittman; H C Lane; F G Witebsky; L L Gosey; M D Hoggan; A S Fauci
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

4.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  Mycobacterioses and the acquired immunodeficiency syndrome. Joint Position Paper of the American Thoracic Society and the Centers for Disease Control.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-08

6.  [Mycobacterioses in patients with HIV infection].

Authors:  M Flepp; K Rhyner; R Lüthy; P Greminger; U Vurma-Rapp; C Wolfisberg; A Burnens; W Siegenthaler
Journal:  Dtsch Med Wochenschr       Date:  1988-05-06       Impact factor: 0.628

Review 7.  HIV persistence in monocytes leads to pathogenesis and AIDS.

Authors:  C D Pauza
Journal:  Cell Immunol       Date:  1988-04-01       Impact factor: 4.868

8.  Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.

Authors:  A J Crowle; N Elkins; M H May
Journal:  Am Rev Respir Dis       Date:  1988-05

9.  Inhibition by normal human serum of Mycobacterium avium multiplication in cultured human macrophages.

Authors:  A J Crowle; P Poche
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.

Authors:  A J Crowle; A Y Tsang; A E Vatter; M H May
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

  10 in total
  8 in total

1.  Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages.

Authors:  Sharad Pathak; Tore Wentzel-Larsen; Birgitta Asjö
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

2.  Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.

Authors:  M Denis; E O Gregg
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

Review 3.  Mycobacterium avium complex: advances in therapy.

Authors:  D V Havlir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 4.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Envelope glycoprotein (gp120) from HIV-1 enhances Mycobacterium avium growth in human bronchoalveolar macrophages; an effect mediated by enhanced prostaglandin synthesis.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

6.  Characterization of inhibition of Mycobacterium avium replication in macrophages by normal human serum.

Authors:  G S Douvas; M H May; E Ross; A J Crowle
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Preservation of monocyte effector functions against Mycobacterium avium-M. intracellulare in patients with AIDS.

Authors:  J L Johnson; H Shiratsuchi; H Toba; J J Ellner
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Comparison of the abilities of Mycobacterium avium and Mycobacterium intracellulare to infect and multiply in cultured human macrophages from normal and human immunodeficiency virus-infected subjects.

Authors:  A J Crowle; E R Ross; D L Cohn; J Gilden; M H May
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.